ANKHD1 Silencing Delays S Phase Progression in Multiple Myeloma Cells Via Activation of ATM/ATR-CDC25a Pathway

被引：0
|
作者：
Anamika, Dhyani [1 ]
Favaro, Patricia [2 ]
Saad, Sara Teresinha Olalla [3 ]
机构：
[1] Univ Campinas Hemocentr Unicamp, Hematol & Hemotherapy Ctr, Inst Nacl Ciencia Tecnol Sangue, Campinas, Brazil
[2] Univ Fed Sao Paulo, Diadema, Sao Paulo, Brazil
[3] Univ Estadual Campinas, Hematol & Blood Transfus Ctr, Campinas, Brazil
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5624.5624
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5624
引用
收藏
页数：4
相关论文
共 33 条
  • [31] Cyclovirobuxine D inhibits growth and progression of non-small cell lung cancer cells by suppressing the KIF11-CDC25C-CDK1-CyclinB1 G2/M phase transition regulatory network and the NFκB/JNK signaling pathway
    Xue, Ting
    Chen, Yaodong
    Xu, Jia
    Du, Weiqin
    Kong, Pengzhou
    Zhang, Xinri
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2023, 62 (05)
  • [32] Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3′-kinase/Akt signaling pathway
    Chakravarthy, MV
    Abraha, TW
    Schwartz, RJ
    Fiorotto, ML
    Booth, FW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (46) : 35942 - 35952
  • [33] The PP242 Mammalian Target of Rapamycin (mTOR) Inhibitor Activates Extracellular Signal-regulated Kinase (ERK) in Multiple Myeloma Cells via a Target of Rapamycin Complex 1 (TORC1)/Eukaryotic Translation Initiation Factor 4E (eIF-4E)/RAF Pathway and Activation Is a Mechanism of Resistance
    Hoang, Bao
    Benavides, Angelica
    Shi, Yijiang
    Yang, Yonghui
    Frost, Patrick
    Gera, Joseph
    Lichtenstein, Alan
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (26) : 21796 - 21805
1234